Black Diamond Therapeutics (BDTX) Times Interest Earned (2018 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly Times Interest Earned came in at -$9.88 in Q1 2026, down 120.1% YoY from $49.17 in Q1 2025, and up 36.06% on a QoQ basis from -$15.46 in Q4 2025.
Black Diamond Therapeutics (BDTX) Times Interest Earned (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has 8 years of Times Interest Earned data on file, last reported at -$9.88 in Q1 2026.
- Quarterly Times Interest Earned fell 120.1% year-over-year to -$9.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.85 (down 1195.11% YoY) and the FY2025 annual result came in at $0.1, up 116.32% from the prior year.
- Times Interest Earned climbed to -$9.88 in Q1 2026, from -$15.46 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $49.17 in Q1 2025 to a low of -$36.58 in Q1 2022.
- A 5-year average of -$8.42 and a median of -$9.88 in 2026 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 362.29% in 2025, down 2833.33% in 2025.
- Tracing BDTX's Times Interest Earned over 5 years: stood at -$20.79 in 2022, then rose by 7.13% to -$19.31 in 2023, then rose by 14.66% to -$16.48 in 2024, then grew by 6.18% to -$15.46 in 2025, then jumped by 36.06% to -$9.88 in 2026.
- The last three Times Interest Earned figures came in at -$9.88 (Q1 2026), -$15.46 (Q4 2025), and -$1.99 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Black Diamond Therapeutics | 125.92 Mn | 15.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -98.83 |
| Mar 31, 2026 | -9.88 |
| Dec 31, 2025 | -15.46 |
| Sep 30, 2025 | -1.99 |
| Jun 30, 2025 | -22.98 |
| Mar 31, 2025 | 49.17 |
| Dec 31, 2024 | -16.48 |
| Sep 30, 2024 | -2.46 |
| Jun 30, 2024 | -0.78 |
| Mar 31, 2024 | -18.75 |
| Dec 31, 2023 | -19.31 |
| Sep 30, 2023 | -0.76 |
| Jun 30, 2023 | -1.77 |
| Mar 31, 2023 | -20.51 |
| Dec 31, 2022 | -20.79 |
| Sep 30, 2022 | -0.62 |
| Jun 30, 2022 | -3.19 |
| Mar 31, 2022 | -36.58 |
| Dec 31, 2021 | -43.18 |
| Sep 30, 2021 | -4.20 |